Methods and compositions for treating IgE-related disease using NNT1-inhibitors

Details for Australian Patent Application No. 2005232321 (hide)

Owner Amgen Inc.

Inventors Senaldi, Giorgio

Agent Shelston IP

Pub. Number AU-A-2005232321

Parent 2001283451

Filing date 14 November 2005

Wipo publication date 1 December 2005

International Classifications

A61P 037/08 Drugs for immunological or allergic disorders

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 038/17 Medicinal preparations containing peptides - from animals

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C07K 016/24 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

1 December 2005 Application Open to Public Inspection

  Published as AU-A-2005232321

1 December 2005 Complete Application Filed

12 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005232322-Method and system for exchanging data between computer systems and auxiliary displays

2005232320-A spout for a container